Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels

British Journal of Pharmacology
D K Song, F M Ashcroft

Abstract

1. We examined the effect of the sulphonylurea glimepiride on three types of recombinant ATP-sensitive potassium (K(ATP)) channels. 2. K(ATP) channels share a common pore-forming subunit, Kir6.2, which associates with different sulphonylurea receptor isoforms (SUR1 in beta-cells, SUR2A in heart and SUR2B in smooth muscle). 3. Kir6.2 was coexpressed with SUR1, SUR2A or SUR2B in Xenopus oocytes and macroscopic K(ATP) currents were recorded from giant inside-out membrane patches. Glimepiride was added to the intracellular membrane surface. 4. Glimepiride inhibited Kir6.2/SUR currents by interaction with two sites: a low-affinity site on Kir6.2 (IC(50)= approximately 400 microM) and a high-affinity site on SUR (IC(50)=3.0 nM for SUR1, 5.4 nM for SUR2A and 7.3 nM for SUR2B). The potency of glimepiride at the high-affinity site is close to that observed for glibenclamide (4 nM for SUR1, 27 nM for SUR2A), which has a similar structure. 5. Glimepiride inhibition of Kir6.2/SUR2A and Kir6.2/SUR2B currents, but not Kir6.2/SUR1 currents, reversed rapidly. 6. Our results indicate that glimepiride is a high-affinity sulphonylurea that does not select between the beta-cell, cardiac and smooth muscle types of recombinant K(ATP) channel, when m...Continue Reading

References

Jan 1, 1990·Cellular Signalling·S J Ashcroft, F M Ashcroft
Nov 1, 1986·Pflügers Archiv : European journal of physiology·G TrubeT Ohno-Shosaku
Jan 1, 1989·Progress in Biophysics and Molecular Biology·F M Ashcroft, P Rorsman
Oct 4, 1996·The Journal of Biological Chemistry·S IsomotoY Kurachi
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·W KramerK Geisen
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K GeisenJ G Papp
Jan 1, 1997·The Journal of Physiology·F M GribbleF M Ashcroft
May 1, 1997·Neuron·J P ClementJ Bryan
Nov 14, 1997·Physiological Reviews·J M QuayleN B Standen
Jan 10, 1998·The Journal of General Physiology·S Shyng, C G Nichols
Apr 29, 1998·British Journal of Pharmacology·R Barrett-Jolley, G A McPherson
Jul 31, 1998·Trends in Neurosciences·F M Ashcroft, F M Gribble
May 29, 1999·Molecular Pharmacology·H DörschnerM Schwanstecher
Dec 22, 1999·The Journal of Biological Chemistry·M MatsuoK Ueda

❮ Previous
Next ❯

Citations

Aug 27, 2003·Metabolism: Clinical and Experimental·Guntram Schernthaner
Mar 8, 2003·Journal of Diabetes and Its Complications·Fiona M Gribble, Frank Reimann
Mar 8, 2003·Journal of Diabetes and Its Complications·Fatima Z G A CyrinoEliete Bouskela
Jan 30, 2002·British Journal of Pharmacology·Jocelyn E Manning FoxPeter E Light
Jul 30, 2002·British Journal of Pharmacology·Annette HambrockUlrich Quast
Mar 11, 2003·Journal of Cardiovascular Electrophysiology·William C Cole, Odile Clément-Chomienne
Sep 20, 2011·Diabetes, Obesity & Metabolism·A S AbdelmoneimS H Simpson
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Veronica Lang, Peter E Light
Nov 28, 2012·Future Cardiology·John R UssherJagdip S Jaswal
Jul 11, 2003·Clinical Therapeutics·Massimo Massi-Benedetti
Jan 9, 2010·Expert Opinion on Drug Metabolism & Toxicology·Vanessa J BriscoeStephen N Davis
Feb 20, 2010·Archives of Physiology and Biochemistry·Günter MüllerWendelin Frick
Oct 2, 2015·Indian Journal of Endocrinology and Metabolism·Sanjay KalraUditha Bulughapitiya
Apr 1, 2014·Orvosi hetilap·Gábor Winkler
Dec 12, 2002·Diabetes·Peter ProksFrances Ashcroft
Apr 17, 2003·European Journal of Clinical Pharmacology·A HolsteinE-H Egberts
Nov 4, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yu DongChang-Yu Li
Feb 19, 2014·Diabetes, Obesity & Metabolism·S E Holden, C J Currie
Aug 13, 2004·European Journal of Clinical Investigation·G SchernthanerK M Shaw
Nov 25, 2018·Diabetes, Obesity & Metabolism·Ruth L M Cordiner, Ewan R Pearson
Feb 18, 2003·Fundamental & Clinical Pharmacology·Denis RavelEliete Bouskela
Mar 19, 2020·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Waheeda NasreenMohammad A Halim
Apr 13, 2011·Molecular and Cellular Biochemistry·Prashant D Phadatare, V M Chandrashekhar
May 23, 2006·Molecular and Cellular Biochemistry·S Satyanarayana, Eswar K Kilari
Jan 18, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·K M PantaloneR S Zimmerman
May 14, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Yousef Al-SalehNasser M Al-Daghri
Sep 8, 2021·Journal of Experimental & Clinical Cancer Research : CR·Hyunkoo KangBuHyun Youn
Nov 12, 2021·Expert Opinion on Pharmacotherapy·Brian TomlinsonChristopher Wai Kei Lam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.